Muhanad Taha

Antiphospholipid antibodies in COVID-19: a meta-analysis and systematic review http://orcid.org/0000-0002-5867-1929Muhanad Taha and Lobelia Samavati Department of Pulmonary/Critical Care, Wayne State University, Detroit, Michigan, USA Correspondence to Dr Lobelia Samavati; lsamavat{at}med.wayne.edu Abstract Background Many studies reported high prevalence of antiphospholipid antibodies (aPL) in patients with COVID-19 raising questions about its true prevalence and its clinical impact on the...

Introduction The coronavirus disease 19 (COVID-19) is a highly transmittable viral infection caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) [1]. On presentation, most infected individuals exhibit dry cough, dyspnea, and bilateral ground‐glass opacities on radiographic images [2].